Pharma Mar, S.A. (LON:0RC6)

Pharma Mar Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,138	1,149	641	1,027	867	1,177
Market Cap Growth	-14.13%	79.24%	-37.61%	18.42%	-26.28%	75.82%
Enterprise Value	1,054	1,073	527	900	728	1,054
Last Close Price	66.52	65.14	35.04	55.04	45.47	60.59
PE Ratio	38.34	53.17	649.51	23.46	11.12	9.57
PS Ratio	7.27	7.94	4.67	5.90	4.49	4.87
PB Ratio	6.60	6.67	3.82	5.19	5.81	12.78
P/TBV Ratio	6.64	6.70	3.84	5.22	5.84	12.91
P/FCF Ratio	77.97	-	-	39.30	57.78	4.76
P/OCF Ratio	61.38	230.47	-	30.22	40.22	4.71
EV/Sales Ratio	6.75	7.42	3.84	5.17	3.77	4.36
EV/EBITDA Ratio	41.62	128.91	-	22.60	9.12	7.39
EV/EBIT Ratio	55.00	200.70	-	24.11	9.37	7.51
EV/FCF Ratio	72.22	-	-	34.42	48.46	4.26
Debt / Equity Ratio	0.26	0.25	0.23	0.19	0.28	0.55
Debt / EBITDA Ratio	1.73	4.19	48.68	0.91	0.51	0.35
Debt / FCF Ratio	3.01	-	-	1.45	2.76	0.21
Asset Turnover	0.53	0.51	0.43	0.52	0.66	1.19
Inventory Turnover	0.20	0.18	0.29	0.71	1.46	1.32
Quick Ratio	2.03	2.29	1.98	2.18	2.93	2.31
Current Ratio	2.73	3.03	2.63	2.83	3.42	2.59
Return on Equity (ROE)	17.91%	13.00%	0.55%	24.62%	66.18%	249.16%
Return on Assets (ROA)	4.08%	1.17%	-0.65%	6.91%	16.54%	43.04%
Return on Invested Capital (ROIC)	19.47%	7.21%	-4.85%	77.52%	-	808.09%
Return on Capital Employed (ROCE)	8.70%	2.40%	-1.60%	14.20%	32.80%	66.60%
Earnings Yield	2.61%	1.88%	0.15%	4.26%	8.99%	10.45%
FCF Yield	1.28%	-0.65%	-3.83%	2.54%	1.73%	21.01%
Dividend Yield	0.89%	1.02%	1.61%	1.05%	1.20%	0.89%
Payout Ratio	41.02%	43.71%	1028.06%	23.83%	11.71%	6.42%
Buyback Yield / Dilution	-	1.98%	0.81%	0.12%	1.31%	0.77%
Total Shareholder Return	0.89%	2.99%	2.42%	1.17%	2.51%	1.65%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.